NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
Fudan University
German Cancer Research Center
CHA University
Groupe Francais De Pneumo-Cancerologie
Shanghai Proton and Heavy Ion Center